PO No :PO2364528489-926

Name : Mr.ARVIND KUMAR :

Age/Gender : 30/Male Registration Date : 16-Nov-22 10:51 AM
Patient ID : OKH400639 Collection Date : 16/Nov/2022 06:06AM
Barcode ID / Order ID : D0391862 / 6036274 Sample Receive Date : 16/Nov/2022 12:17PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 16/Nov/2022 03:46PM

BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Interval Method

Lipid Profile
Cholesterol - Total 216 mg/dL Adults: Enzymatic
Desirable <200,
Borderline High 200-239,
High >=240
Triglycerides 138 mg/dL Normal: <150, GPO
Borderline: 150 - 199,
High:200-499,
Very High>=500
Cholesterol - HDL 44 mg/dL Low(undesirable, high Elimination/catalase
risk):<40
High(desirable, low
risk):>=60
Cholesterol - LDL 145 mg/dL Desirable: <100 Calculated
Above desirable: 100-
129
Borderline high: 130-159
High: 160-189
Very high: >=190
Cholesterol- VLDL 28 mg/dl <30 Calculated
Cholesterol : HDL Cholesterol 4.9 Ratio Desirable : 3.5-4.5 Calculated
High Risk : >5
LDL : HDL Cholesterol 3.31 Ratio Desirable : 2.5-3.0 Calculated
High risk : >3.5
Non HDL Cholesterol 172 mg/dl Desirable:< 130, Calculated
Above Desirable:130 -
159,
Borderline High:160 -
189,
High:190 - 219,
Very High: >= 220

Page 1 of 4
PO No :PO2364528489-926
Name : Mr.ARVIND KUMAR :
Age/Gender : 30/Male Registration Date : 16-Nov-22 10:51 AM
Patient ID : OKH400639 Collection Date : 16/Nov/2022 06:06AM
Barcode ID / Order ID : D0391862 / 6036274 Sample Receive Date : 16/Nov/2022 12:17PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 16/Nov/2022 03:46PM

BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Interval Method

Comment:

Measurements in the same patient can show physiological & analytical variations. Three serial samples 1 week apart
are recommended for Total Cholesterol, Triglycerides, HDL & LDL Cholesterol.
Lipid Association of India (LAI) recommends screening of all adults above the age of 20 years for Atherosclerotic
Cardiovascular Disease (ASCVD) risk factors, especially lipid profile. This should be done earlier if there is a family
history of premature heart disease, dyslipidemia, obesity, or other risk factors.
The LAI recommends LDL-C as the primary target and non-HDL-C as a co-primary target, for lipid-lowering therapy.
Non-HDL Cholesterol comprises the cholesterol carried by all atherogenic particles, including LDL, IDL, VLDL & VLDL
remnants, Chylomicron remnants and Lp(a).
Apo B measurement is recommended in high-risk subjects after LDL-C and non-HDL-C goals have been achieved.
Additional testing for Apolipoprotein B, hsCRP, Lp(a ) and LP-PLA2 should be considered among patients with
moderate risk for ASCVD for risk refinement.

Updated 2020 risk stratification approach recommended by the Lipid Association of India

Risk Factors/Markers
Moderate-risk
Major ASCVD Risk Factors Other High risk features nonconventional risk
factors
1. Age ≥45 years in males and 1. Diabetes with 0-1 other major ASCVD Risk factors and no 1. Coronary calcium score
≥55 years in females evidence of target organ damage 100-299
2. Family history of premature
2. CKD Stage 3B or 4 2. Increased carotid IMT
ASCVD
3. Current cigarette smoking and 3. Familial hypercholesterolemia (other than familial 3. Lipoprotein (a) 20-49
tobacco use homozygous hypercholesterolemia mg/dL
4. High blood pressure 4. Extreme of a single risk factor 4. Impaired Fasting Glucose*
5. Increased waist
5. Low HDL-C 5. Coronary calcium score ≥300
circumference**
6. Apolipoprotein B ≥110
6. Non-stenotic carotid plaque
mg/dL
7. Lipoprotein (a) ≥50 mg/dL 7. hsCRP ≥2 mg/L***

Risk groups
Low risk Moderate risk High risk Very High risk Extremely High risk

Page 2 of 4
PO No :PO2364528489-926
Name : Mr.ARVIND KUMAR :
Age/Gender : 30/Male Registration Date : 16-Nov-22 10:51 AM
Patient ID : OKH400639 Collection Date : 16/Nov/2022 06:06AM
Barcode ID / Order ID : D0391862 / 6036274 Sample Receive Date : 16/Nov/2022 12:17PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 16/Nov/2022 03:46PM

BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Interval Method

2 Major
≥3 major ASCVD
ASCVD risk Pre-existing ASCVD Category A Category B
risk factor
factors
0-1 major
Low risk group 2 major ASCVD risk
ASCVD risk Diabetes ≥2 other CAD ≥1 feature of very high risk
≥1 moderate- factor with ≥1
factor and major risk factors or group or recurrent ACS (within
risk moderate-risk
Lifetime CVD evidence of target one year) despite LDL-C ≤50
nonconventional nonconventional risk
risk <30% organ damage mg/dL or polyvascular disease
risk factors factors
Lifetime CVD ≥1 other high risk Familial homozygous
risk ≥30% features Hypercholesterolemia

* A fasting blood sugar level from 100 to 125 mg/dl. It should be confirmed by repeat testing; **Waist circumference is to be
measured at the superior border of the iliac crest just after expiration. Increased waist circumference is defined as >90 cm
in men and >80 cm in women. If increased waist circumference is the only risk factor, it should again be measured after 6
months after initiating heart-healthy lifestyle measures; ***On two occasions at least 2 weeks apart. For reclassifying moderate
risk group only.
Newer treatment goals and statin initiation thresholds based on the risk categories proposed by LAI in 2020
Risk groups Treatment Goals Consider Drug Therapy
LDL-C (mg/dL) Non-HDL (mg/dL) LDL-C (mg/dL) Non-HDL (mg/dL)
Extreme Risk Group Category A <50 (Optional goal ≤30) <80 (Optional goal ≤60) ≥50 ≥80
Extreme Risk Group Category B ≤30 ≤60 >30 >60
Very High Risk <50 <80 ≥50 ≥80
High Risk <70 <100 ≥70 ≥100
Moderate Risk <100 ≥100 ≥130
Low risk <100 ≥130* ≥160*
*After an adequate non-pharmacological intervention for at least 3 months

Page 3 of 4
PO No :PO2364528489-926
Name : Mr.ARVIND KUMAR :
Age/Gender : 30/Male Registration Date : 16-Nov-22 10:51 AM
Patient ID : OKH400639 Collection Date : 16/Nov/2022 06:06AM
Barcode ID / Order ID : D0391862 / 6036274 Sample Receive Date : 16/Nov/2022 12:17PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 16/Nov/2022 04:23PM

Immunology
Test Name Result Unit Bio. Ref. Interval Method

Vitamin D (25-OH) 15.3 ng/mL Deficiency:< 20, CLIA

Insufficiency:20-29,
Sufficiency:30 - 100,
Toxicity possible:> 100

Comment:

Vitamin D is a fat-soluble steroid prohormone involved in the intestinal absorption of calcium and the regulation of calcium
homeostasis.
Two forms of vitamin D are biologically relevant - vitamin D3 (Cholecalciferol) and vitamin D2 (Ergocalciferol).
Both vitamins D3 and D2 can be absorbed from food but only an estimated 10-20perc. of vitamin D is supplied through
nutritional intake.
Vitamin D is converted to the active hormone 1,25-(OH)2-vitamin D (Calcitriol) through two hydroxylation reactions. The
first hydroxylation converts vitamin D into 25-OH vitamin D and occurs in the liver. The second hydroxylation converts 25-
OH vitamin D into the biologically active 1,25-(OH)2-vitamin D and occurs in the kidneys as well as in many other cells of
the body.
Most cells express the vitamin D receptor and about 3perc. of the human genome is directly or indirectly regulated by the
vitamin D endocrine system.
The major storage form of vitamin D is 25-OH vitamin D and is present in the blood at up to 1,000 fold higher
concentration compared to the active 1,25-(OH)2-vitamin D. 25-OH vitamin D has a half-life of 2-3 weeks vs. 4 hours for
1,25-(OH)2-vitamin D. Therefore, 25-OH vitamin D is the analyte of choice for determination of the vitamin D status.
Risk factors for vitamin D deficiency include low sun exposure, inadequate intake, decreased absorption, abnormal
metabolism, vitamin D resistance and and liver or kidney diseases.
Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases resulting in impaired bone metabolism (like
rickets, osteomalacia).
Recently, many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases
have been linked to vitamin D deficiency.

Utility Quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D).

*** End Of Report ***

Page 4 of 4
Thank you for choosing us as your healthcare partner
Tata 1mg Labs, India’s trusted diagnostics lab chain, has a nationwide network of 9
diagnostics labs, serving over a million customers each year across 35 cities. Equipped
with the latest technologies, our diagnostics chain brings home to you an extensive
catalog of tests.

20 Lakh+ Detailed Accurate & Sample collection by

satisfied customers information of timely reports vaccinated & certified
each test professionals

What makes us India’s trusted diagnostic services?

1. All samples are processed under the

supervision of highly qualified Pathologists,
Microbiologists, Biochemists and Molecular
Scientists. Our labs are operated by a team
of expert medical professionals with a
collective experience of 200+ years.

2. We ensure that all tests are carried out with

utmost care, in accordance with the
accepted national and international norms
and clinical safety standards such as good
laboratory practices by WHO and ICMR.

3.
“
Our lab test reports undergo multiple levels
of meticulous processing and detailed
verification. Every single report goes
“
through a 3-step review process and is
verified by a doctor holding a postgraduate
degree in Pathology or Microbiology.

CONFUSED ABOUT YOUR REPORTS?

Now, consult India’s top doctors from the
comfort of your home.

CLAIM YOUR FREE CONSULTATION

Why are regular health checkups important?
Help in early detection of diseases Help cut down any future
& prevent severe complications healthcare cost

Identify underlying stress-related Help monitor overall health of

disease/condition you & your family

Our most booked

preventive health checkups:

Comprehensive Full Body Good Health Silver

Checkup Gold (70+ Tests) Package (50+ Tests)

*Prices are subject to change as per location

CBC, Thyroid Profile, Lipid Profile, CBC, Diabetes Screening, Lipid Profile,
Iron Profile, Vitamin Profile, CRP, Thyroid Profile, Kidney Panel,
Urine Routine Liver Panel

A full body check up that screens you Helps you make better & healthier
for common health conditions related lifestyle choices by giving you an
to thyroid, heart, liver, kidney, bones overview of your health status
and blood

Book now starting at ₹1999* Book now starting at ₹599*

Check out and compare our most

COMPARE HERE
popular packages here
Common symptoms may indicate underlying
health conditions!

What's causing your fever?

Get timely diagnosis with

BOOK NOW
Fever Package Extensive
Tests for Dengue, Malaria, Typhoid & Chikungunya

Feeling tired and fatigued often?

Check your Vitamin D,

BOOK NOW
B12 & B9 levels with
Vitamin Profile

For booking assistance, contact us on

Call: 1800-212-2323 WhatsApp: 9717-719-814

Book your test on 1mg.com/labs

Home sample Free doctor 100% vaccinated Trusted &

collection consultation phlebotomists certified labs

Conditions of Laboratory Testing & Reporting:

*Test results released pertain to the sample,as received *Laboratory investigations are only a tool to facilitate in arriving at
a diagnosis and should be clinically correlated by the interpreting clinician.*Result delays may happen because of
unforeseen or uncontrollable circumstances.*Test report may vary depending on the assay method used *Test results may
show inter-laboratory variations *Test results are not valid for medico-legal purposes *Please mail your queries related to
test results to Customer Care mail ID cs.labs@1mg.com

Disclaimer: Results relate only to the sample received. Test results marked “BOLD” indicate abnormal results i.e., higher or
lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report
cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg
Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive
of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only.